Mike Wierzba
GlaxoSmithKline, United States
Director, GRA, Precision Medicine and Digital Health
Mike Wierzba is a Director within the Precision Medicine & Digital Health, Global Regulatory Affairs team at GSK where he is the diagnostic regulatory lead for multiple development programs and leads efforts related to IVDR. Mike is a participant in EFPIA Precision Medicine Working Group. Prior to moving to Pharma, Mike was the global regulatory lead for multiple companion diagnostics programs for IHC and ISH devices at Roche Diagnostics. Before transitioning to Regulatory, Mike was a Scientist in CDx Assay Development and spent 15 years in academic research focusing on cell signaling pathways. Mike has a PhD in Molecular and Cellular Biology from the University of Arizona, is passionate about diversity, equity, and inclusion initiatives.
or sign up with email →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
